HC BIOLOGICS LLC
MIAMI, FLORIDA

HC Biologics LLC, founded on October 28, 2015, is headquartered in Miami, Florida. Renowned for offering custom production solutions, the company has leveraged its substantial global experience and collaborative efforts with top-tier tissue banks across the United States to cultivate an array of allografts and tissue-based medical products. These offerings are designed to effectively address diverse clinical challenges faced by patients. HC Biologics is a prominent provider of high-quality allografts globally, catering to surgical needs in spinal, orthopedic, oncology, neuro, trauma, dental, and oral-maxillofacial disciplines. The company prides itself on the superior quality of its spinal products. As both manufacturers and global distributors, HC Biologics possesses a comprehensive portfolio that ensures surgeons have access to flexible and reliable intraoperative solutions. Furthermore, being pioneers in employing 3-D printing for custom orthopedic implants and instruments has allowed them to deliver cost-effective, high-standard hip and knee implants that enhance surgical efficiency as well as patient outcomes. Registered under the Florida Department of State as a Florida Limited Liability Company (FloridaModels.Dos.FloridaCompanyStatus), HC Biologics is listed with FEIN number 47-5493353. The firm's mailing address is 1221 Brickell Avenue, Suite 900, Miami, FL 33131. For inquiries and further details regarding their innovative products and services, the company can be contacted via phone at (786) 613-1974 or through its online presence on their website hcbiologics.com. As of October 18, 2016, HC Biologics underwent reinstatement and is slated for an annual report due by January 3, 2025.